Circulating tumor cells in chronic obstructive pulmonary disease patients
C. Sanfiorenzo, K. Risso, V. Sellam, V. Hofman, M. Ilie, E. Long, E. Selva, C. Bonnetaud, C. H. Marquette, P. Hofman (Nice, France)
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Session: Innovative diagnostic methods for lung cancer
Session type: Oral Presentation
Number: 4506
Abstract Introduction and hypothesis: Migration of circulating tumor cells (CTC) in the blood stream is certainly an early event occuring during lung carcinogenesis. Chronic obstructive pulmonary disease (COPD), even in early stages, is associated with a higher incidence of lung cancer in smokers and ex-smokers. The purpose of this study was to look for the presence of CTC in a cohort of smokers having a COPD.Methods : The presence of CTC was searched in 50 COPD patients, using both the CellSearch (CS) and the isolation by size of epithelial tumor (ISET) cells methods. Results were compared to the detection of CTC in a group of 30 patients with stage IIIB or IV non-small cell lung cancer (NSCLC) and in a group of 30 healthy individuals.Results: 4/50 (8%) COPD patients had CTC (mean=4; range, 2-8 CTC) detected by CS and/or ISET methods. 18/30 (60%) of advanced stages NSCLC patients showed CTC (mean=16; range, 2-86). No CTC were detected in healthy individuals.Conclusion : The detection of CTC using the CS and/or the ISET methods is a rare biological event in COPD smoker patients. In this regard, the potentiality of the CS and the ISET methods as tools for detecting early blood biomarkers of lung carcinogenesis is challenging.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Sanfiorenzo, K. Risso, V. Sellam, V. Hofman, M. Ilie, E. Long, E. Selva, C. Bonnetaud, C. H. Marquette, P. Hofman (Nice, France). Circulating tumor cells in chronic obstructive pulmonary disease patients. Eur Respir J 2011; 38: Suppl. 55, 4506
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Circulating adhesion molecules in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004
Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008
Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001
Angiogenic status in patients with chronic obstructive pulmonary disease. Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Endothelial progenitor cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008
Circulating obestatin in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: comorbidities Year: 2010
Circulating endothelial progenitor cells and chronic pulmonary diseases Source: Eur Respir J 2011; 37: 426 Year: 2011
Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009
Accumulation of dendritic cells in small airways of patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis Year: 2007
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
Circulating fibrocytes in patients with chronic obstructive asthma Source: Annual Congress 2009 - Fibrocytes: a key player in fibrotic airway and pulmonary diseases Year: 2009
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
Serum leptin levels in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 259s Year: 2002
Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease Source: Annual Congress 2008 - COPD Year: 2008
Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010
Correlation between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases Year: 2007
Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005
Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
The effect of inferon on oxygen-dependent metabolism of blood cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008